LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe

NCT00677248 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Ezetimibe and placebo
DRUG: Eprotirome and ezetimibe

Sponsor

Karo Bio AB